The Generic Genetic (GG) Corporation pays no cash dividends currently and is not expected to do so for the next four years. Its latest EPS was $5, all of which was reinvested in the company. The firm's expected ROE for the next four years is 20% p.a., during which time it is expect to continue to reinvest all of its earnings. Starting in year 5, the firm's ROE on new investments is expected to fall to 15% per year. GG's market capitalization rate is 15% per year. What is your estimate of GG's intrinsic value per share?